Evidence map›Paper›PMID 36813828›Full record

ArticleScientific reports2023

Prevalence of family history of cancer in the NC-CCAPH consortium of Japan.

Sarah Krull Abe, Hikaru Ihira, Tetsuji Minami, Takuya Imatoh, Yosuke Inoue, Kota Tsutsumimoto, Nozomu Kobayashi, Rena Kashima, Maki Konishi, Takehiko Doi and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sarah Krull AbeDivision of Prevention, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. saabe@ncc.go.jp.
Hikaru IhiraDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Tetsuji MinamiDivision of Prevention, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
Takuya ImatohDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Yosuke InoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Kota TsutsumimotoDepartment of Preventive Gerontology, Center for Gerontology and Social Science National Center for Geriatrics and Gerontology, Aichi, Japan.
Nozomu KobayashiCancer Screening Center, National Cancer Center Hospital, Tokyo, Japan.
Rena KashimaDepartment of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Maki KonishiDepartment of Epidemiology and Prevention, Center for Clinical Sciences, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Takehiko DoiDepartment of Preventive Gerontology, Center for Gerontology and Social Science National Center for Geriatrics and Gerontology, Aichi, Japan.
Masayuki TeramotoDepartment of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Isamu KabeKUBOTA Corporation, Tokyo, Japan.
Sangyoon LeeDepartment of Preventive Gerontology, Center for Gerontology and Social Science National Center for Geriatrics and Gerontology, Aichi, Japan.
Makoto WatanabeDivision of Preventive Healthcare, National Cerebral and Cardiovascular Center, Osaka, Japan.
Seitaro DohiMitsui Chemicals, Inc., Tokyo, Japan.
Yukie SakaiDepartment of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yukiko NishitaDepartment of Epidemiology of Aging, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Aichi, Japan.
Naho MorisakiDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.
Hisateru TachimoriDepartment of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.
Yoshihiro KokuboDepartment of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Taiki YamajiDivision of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Hiroyuki ShimadaDepartment of Preventive Gerontology, Center for Gerontology and Social Science National Center for Geriatrics and Gerontology, Aichi, Japan.
Tetsuya MizoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Norie SawadaDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Shoichiro TsuganeDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Motoki IwasakiDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Manami InoueDivision of Prevention, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to identify the prevalence of family history of cancer using cohorts participating in the Japanese National Center Cohort Collaborative for Advancing Population Health (NC-CCAPH). We pooled data from seven eligible cohorts of the Collaborative with available data on family history of cancer. Prevalence of family history of cancer and corresponding 95% confidence intervals are presented for all cancers and selected site-specific cancers for the total population and stratified by sex, age, and birth cohort. Prevalence of family history of cancer increased with age ranging from 10.51% in the 15 to 39 year age category to 47.11% in 70-year-olds. Overall prevalence increased in birth cohorts from ≤ 1929 until 1960 and decreased for the next two decades. Gastric cancer (11.97%) was the most common site recorded for family members, followed by colorectal and lung (5.75%), prostate (4.37%), breast (3.43%) and liver (3.05%) cancer. Women consistently had a higher prevalence of family history of cancer (34.32%) versus men (28.75%). Almost one in three participants had a family history of cancer in this Japanese consortium study highlighting the importance of early and targeted cancer screening services.

Indexed as

FamilyStomach NeoplasmsBreastFemaleHumansJapanMalePrevalenceRisk Factors

Identifiers

PMID36813828
PMCPMC9947111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.